Mp alpha1 receptor: Clinical Trials

3 trials of Mp alpha1 receptor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 enrolling by invitation. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Enrolling by invitation 1

Follow Mp alpha1 receptor: new trials by email Literature Review of Mp alpha1 receptor trials Research Report on Mp alpha1 receptor

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
Alpha-1 MP - Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency
Phase 3Enrolling by invitationGrifols Therapeutics LLC2902016-07-012026-06-23
Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)
Alpha-1 MP, 0.9% Sodium Chloride for Injection, USP - Pulmonary Emphysema in Alpha-1 PI Deficiency
Phase 3CompletedGrifols Therapeutics LLC3452014-04-012026-10-01
Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults
Alpha-1 MP, alpha-1 proteinase inhibitor (human) - Alpha 1-Antitrypsin Deficiency
Phase 3CompletedGrifols Therapeutics LLC242006-05-012014-09-09

Conditions studied

Pulmonary Emphysema (3)  ·  alpha 1-Antitrypsin Deficiency (3)

Sponsors

Grifols Therapeutics LLC (3)

Countries

United States (3)  ·  Australia (2)  ·  Canada (2)  ·  Denmark (2)  ·  Estonia (2)  ·  Finland (2)  ·  France (2)  ·  Moldova (2)  ·  New Zealand (2)  ·  Poland (2)  ·  Russia (2)  ·  Sweden (2)  ·  Argentina (1)  ·  Brazil (1)  ·  Germany (1)

Top investigators

Kim Hanna, MSc (1)

Results publications

PMID 20920295, PMID 25727857